Bolt Biotherapeutics Stock Performance

BOLT Stock  USD 4.95  0.03  0.61%   
On a scale of 0 to 100, Bolt Biotherapeutics holds a performance score of 4. The firm shows a Beta (market volatility) of 0.47, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Bolt Biotherapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Bolt Biotherapeutics is expected to be smaller as well. Please check Bolt Biotherapeutics' downside variance, and the relationship between the sortino ratio and accumulation distribution , to make a quick decision on whether Bolt Biotherapeutics' price patterns will revert.

Risk-Adjusted Performance

Soft

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Bolt Biotherapeutics are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively inconsistent essential indicators, Bolt Biotherapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more

Actual Historical Performance (%)

One Day Return
0.61
Five Day Return
(13.61)
Year To Date Return
(14.51)
Ten Year Return
(99.23)
All Time Return
(99.23)
Last Split Factor
1:20
Last Split Date
2025-06-09
1
Acquisition by Miller Richard A Md of 25000 shares of Bolt Biotherapeutics at 1.63 subject to Rule 16b-3
11/25/2025
2
Roamlys Specialty RV Insurance Now Available to Agents on bolts Platform Nationwide
12/03/2025
3
Acquisition by Onetto Nicole of 25000 shares of Bolt Biotherapeutics subject to Rule 16b-3
12/11/2025
4
Disposition of 7614 shares by William Quinn of Bolt Biotherapeutics at 56.0 subject to Rule 16b-3
12/12/2025
5
Published on 2025-12-19 092125 - ulpravda.ru
12/18/2025
6
BOLT SEC Filings - Bolt Biotherapeutics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
12/24/2025
7
Street Watch Why Bolt Biotherapeutics Inc. stock could rally in 2025 - Trade Ideas Short-Term Trading Alerts - moha.gov.vn
01/05/2026
8
Disposition of 1100 shares by Ocallaghan Brian of Bolt Biotherapeutics at 15.364 subject to Rule 16b-3
01/16/2026
9
Acquisition by Sarah Nemec of 1589 shares of Bolt Biotherapeutics at 5.44 subject to Rule 16b-3
01/27/2026
10
Treasury Yields Is Bolt Biotherapeutics Inc. a top pick in the sector - Portfolio Return Summary AI Forecasted Stock Moves - baoquankhu1.vn
02/09/2026
Begin Period Cash Flow12.6 M
Total Cashflows From Investing Activities57.6 M

Bolt Biotherapeutics Relative Risk vs. Return Landscape

If you would invest  451.00  in Bolt Biotherapeutics on November 17, 2025 and sell it today you would earn a total of  44.00  from holding Bolt Biotherapeutics or generate 9.76% return on investment over 90 days. Bolt Biotherapeutics is currently generating 0.2384% in daily expected returns and assumes 4.2375% risk (volatility on return distribution) over the 90 days horizon. In different words, 38% of stocks are less volatile than Bolt, and 96% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Bolt Biotherapeutics is expected to generate 5.55 times more return on investment than the market. However, the company is 5.55 times more volatile than its market benchmark. It trades about 0.06 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.13 per unit of risk.

Bolt Biotherapeutics Target Price Odds to finish over Current Price

The tendency of Bolt Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 4.95 90 days 4.95 
about 82.07
Based on a normal probability distribution, the odds of Bolt Biotherapeutics to move above the current price in 90 days from now is about 82.07 (This Bolt Biotherapeutics probability density function shows the probability of Bolt Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Bolt Biotherapeutics has a beta of 0.47 suggesting as returns on the market go up, Bolt Biotherapeutics average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Bolt Biotherapeutics will be expected to be much smaller as well. Additionally Bolt Biotherapeutics has an alpha of 0.0557, implying that it can generate a 0.0557 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Bolt Biotherapeutics Price Density   
       Price  

Predictive Modules for Bolt Biotherapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Bolt Biotherapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.674.919.15
Details
Intrinsic
Valuation
LowRealHigh
4.879.1113.35
Details
4 Analysts
Consensus
LowTargetHigh
20.0222.0024.42
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-5.92-5.92-5.92
Details

Bolt Biotherapeutics Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Bolt Biotherapeutics is not an exception. The market had few large corrections towards the Bolt Biotherapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Bolt Biotherapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Bolt Biotherapeutics within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.06
β
Beta against Dow Jones0.47
σ
Overall volatility
0.61
Ir
Information ratio 0.01

Bolt Biotherapeutics Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Bolt Biotherapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Bolt Biotherapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Bolt Biotherapeutics had very high historical volatility over the last 90 days
Bolt Biotherapeutics has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 7.69 M. Net Loss for the year was (63.12 M) with loss before overhead, payroll, taxes, and interest of (30.07 M).
Bolt Biotherapeutics currently holds about 176.34 M in cash with (61.29 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.68.
Latest headline from news.google.com: Treasury Yields Is Bolt Biotherapeutics Inc. a top pick in the sector - Portfolio Return Summary AI Forecasted Stock Moves - baoquankhu1.vn

Bolt Biotherapeutics Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Bolt Stock often depends not only on the future outlook of the current and potential Bolt Biotherapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Bolt Biotherapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding38.2 M
Cash And Short Term Investments47.3 M

Bolt Biotherapeutics Fundamentals Growth

Bolt Stock prices reflect investors' perceptions of the future prospects and financial health of Bolt Biotherapeutics, and Bolt Biotherapeutics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Bolt Stock performance.

About Bolt Biotherapeutics Performance

Assessing Bolt Biotherapeutics' fundamental ratios provides investors with valuable insights into Bolt Biotherapeutics' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Bolt Biotherapeutics is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.57)(0.60)
Return On Capital Employed(0.78)(0.82)
Return On Assets(0.57)(0.60)
Return On Equity(1.27)(1.21)

Things to note about Bolt Biotherapeutics performance evaluation

Checking the ongoing alerts about Bolt Biotherapeutics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Bolt Biotherapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Bolt Biotherapeutics had very high historical volatility over the last 90 days
Bolt Biotherapeutics has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 7.69 M. Net Loss for the year was (63.12 M) with loss before overhead, payroll, taxes, and interest of (30.07 M).
Bolt Biotherapeutics currently holds about 176.34 M in cash with (61.29 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.68.
Latest headline from news.google.com: Treasury Yields Is Bolt Biotherapeutics Inc. a top pick in the sector - Portfolio Return Summary AI Forecasted Stock Moves - baoquankhu1.vn
Evaluating Bolt Biotherapeutics' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Bolt Biotherapeutics' stock performance include:
  • Analyzing Bolt Biotherapeutics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Bolt Biotherapeutics' stock is overvalued or undervalued compared to its peers.
  • Examining Bolt Biotherapeutics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Bolt Biotherapeutics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Bolt Biotherapeutics' management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Bolt Biotherapeutics' stock. These opinions can provide insight into Bolt Biotherapeutics' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Bolt Biotherapeutics' stock performance is not an exact science, and many factors can impact Bolt Biotherapeutics' stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Additional Tools for Bolt Stock Analysis

When running Bolt Biotherapeutics' price analysis, check to measure Bolt Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bolt Biotherapeutics is operating at the current time. Most of Bolt Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Bolt Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bolt Biotherapeutics' price. Additionally, you may evaluate how the addition of Bolt Biotherapeutics to your portfolios can decrease your overall portfolio volatility.